B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation (CTOTC-08)

Trial Profile

B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation (CTOTC-08)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Rituximab (Primary) ; Antithymocyte globulin; MMF; Steroids; Tacrolimus
  • Indications Lung transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 27 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top